Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells

被引:0
|
作者
Xi-Ping Tang [1 ]
Guo-Du Tang [1 ]
Chun-Yun Fang [1 ]
Zhi-Hai Liang [1 ]
Lu-Yi Zhang [1 ]
机构
[1] Department of Gastroenterology,First Affiliated Hospital,Guangxi Medical University
基金
中国国家自然科学基金;
关键词
Ginsenoside Rh2; Human pancreatic cancer Bxpc-3 cell; Proliferation; Apoptosis; Migration;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
100214 ;
摘要
AIM:To investigate the effects of ginsenoside Rh2 on the human pancreatic cancer cell line Bxpc-3.METHODS:The human pancreatic cancer cell line Bxpc-3 was cultured in vitro and treated with or without ginsenoside Rh2.Growth rates for Bxpc-3 cells were assessed by methyl thiazolyl tetrazolium(MTT) and colony formation assays.Cell cycle changes were analyzed by flow cytometry.Apoptosis was measured by flow cytometry and Hoechst 33258 fluorescence staining.A scratch assay and a Matrigel invasion assay were used to detect cell migration and invasion.Expression of Bax,Bcl-2,survivin,cyclin D1,matrix metalloproteinase(MMP)-2,MMP-9,cleaved caspase-3,caspase-8,and caspase-9 mRNA were determined by reverse transcriptase-polymerase chain reaction(RT-PCR).Bax,Bcl-2,survivin,cyclin D1,cleaved caspase-3,caspase-8 and caspase-9 protein levels were examined by western blotting.Expression of MMP-2 and MMP-9 proteins in culture supernatants were determined by enzymelinked immunosorbent assay(ELISA).RESULTS:Rh2 significantly inhibited Bxpc-3 cell proliferation in a dose-and time-dependent manner,as evaluated by the MTT(P < 0.05) and colony formation assays(P < 0.05).Compared to the control group,Rh2 significantly increased the percentage of Bxpc-3 cells in the G 0 /G 1 phase from 43.32% ± 2.17% to 71.32% ± 1.16%,which was accompanied by a decrease in S phase(from 50.86% ± 1.29% to 28.48% ± 1.18%) and G 2 /M phase(from 5.81% ± 1.19% to 0.20% ± 0.05%) in a dose-dependent manner(P < 0.05),suggesting that Rh2 arrested cell cycle progression at the G 0 /G 1 phase,as measured by flow cytometry.Compared to the control group,cells treated with Rh2 showed significantly higher apoptosis ratios in a dosedependent manner(percentage of early apoptotic cells:from 5.29% ± 2.28% to 38.90% ± 3.42%(F = 56.20,P < 0.05);percentage of late apoptotic cells:from 4.58% ± 1.42% to 36.32% ± 2.73%(F = 86.70,P < 0.05).Rh2 inhibited Bxpc-3 cell migration and invasion,as detected by scratch wound healing assay and Matrigel invasion assay [percentages of scratch wound healing for 12 h,24 h and 48 h(control vs experimental group):37.3% ± 4.8%vs 18.30% ± 1.65%,58.7% ± 3.5% vs 38.00% ± 4.09% and 93.83% ± 4.65% vs 65.50% ± 4.09%,respectively;t = 6.489,t = 6.656 and t = 7.926,respectively,P < 0.05;the number of cells invading at various concentrations(0 μmol/L,35 μmol/L,45 μmol/L and 55 μmol/L):81.10 ± 9.55,46.40 ± 6.95,24.70 ± 6.88 and 8.70 ± 3.34,respectively(F = 502.713,P < 0.05)].RT-PCR,western blotting or ELISA showed that mRNA and protein expression of Bax,cleaved caspase-3 and caspase-9 were upregulated(P < 0.05),while mRNA and protein expression of Bcl-2,survivin,cyclin D1,MMP-2 and MMP-9 were downregulated(P < 0.05).CONCLUSION:Ginsenoside Rh2 inhibits proliferation,migration and invasion and induces apoptosis of the human pancreatic cancer cell line Bxpc-3.
引用
收藏
页码:1582 / 1592
页数:11
相关论文
共 50 条
  • [1] Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells
    Tang, Xi-Ping
    Tang, Guo-Du
    Fang, Chun-Yun
    Liang, Zhi-Hai
    Zhang, Lu-Yi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (10) : 1582 - 1592
  • [2] Inhibition of prostatic cancer growth by ginsenoside Rh2
    Zhang, Qingchuan
    Hong, Bin
    Wu, Songhua
    Niu, Tianli
    TUMOR BIOLOGY, 2015, 36 (04) : 2377 - 2381
  • [3] Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells
    Nakata, H
    Kikuchi, Y
    Tode, T
    Hirata, J
    Kita, T
    Ishii, K
    Kudoh, K
    Nagata, I
    Shinomiya, N
    JAPANESE JOURNAL OF CANCER RESEARCH, 1998, 89 (07): : 733 - 740
  • [4] Structure Modification of Ginsenoside Rh2 and Cytostatic Activity on Cancer Cells
    Liang, Junyu
    Tang, Xiaodong
    Wan, Shanhe
    Guo, Jiayin
    Zhao, Peng
    Lu, Ling
    ACS OMEGA, 2023, 8 (19): : 17245 - 17253
  • [5] Ginsenoside Rh2 Inhibits Migration of Lung Cancer Cells under Hypoxia via mir-491
    Chen, Yingying
    Zhang, Yuqiang
    Song, Wei
    Zhang, Ying
    Dong, Xiu
    Tan, Mingqi
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (13) : 1633 - 1641
  • [6] A stereo-selective growth inhibition profile of ginsenoside Rh2 on human colon cancer cells
    Jeong, Yunju
    Ku, Seockmo
    You, Hyun Ju
    Ji, Geun Eog
    CYTA-JOURNAL OF FOOD, 2019, 17 (01) : 488 - 493
  • [7] The interaction of serum albumin with ginsenoside Rh2 resulted in the downregulation of ginsenoside Rh2 cytotoxicity
    Lin, Yingjia
    Li, Yang
    Song, Zhi-Guang
    Zhu, Hongyan
    Jin, Ying-Hua
    JOURNAL OF GINSENG RESEARCH, 2017, 41 (03) : 330 - 338
  • [8] Anticancer Effects of Ginsenoside Rh2: A Systematic Review
    He, Xin-Ling
    Xu, Xiao-Huang
    Shi, Jia-Jie
    Huang, Mingqing
    Wang, Yitao
    Chen, Xiuping
    Lu, Jin-Jian
    CURRENT MOLECULAR PHARMACOLOGY, 2022, 15 (01) : 179 - 189
  • [9] Anticancer effects and potential mechanisms of ginsenoside Rh2 in various cancer types
    Zhang, Haibo
    Park, Song
    Huang, Hai
    Kim, Eungyung
    Yi, Junkoo
    Choi, Seong-Kyoon
    Ryoo, Zaeyoung
    Kim, Myoungok
    ONCOLOGY REPORTS, 2021, 45 (04)
  • [10] Antiallergic activity of ginsenoside Rh2
    Park, EK
    Choo, MK
    Kim, EJ
    Han, MJ
    Kim, DH
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (11) : 1581 - 1584